Home infusion therapy works with at-home medication given into the patient's body through needle and catheter. The therapy is endorsed by doctors and managed via experienced medical services professionals. It is utilized when oral medication is not viable for the therapy of disorders like malignant growth of tissues such as cancer or tumors and gastrointestinal infections. It is likewise utilized in the treatment of diabetes, cystic fibrosis, dehydration, and intense infections.
Home infusion therapy alludes to the interaction wherein patients get treatment at home through the provision of medications through catheters and needles. Accepting treatment at home rather than clinics or medical care offices is a financially preferable and more convenient option for patients, further driving the requirement for home infusion therapy.
Home infusion therapy permits the patients to keep away from long and superfluous stays in the medical clinics and lessens medical clinic costs. As per the WHO, as of now, all the infections represent 63% of total deaths and 46% of the sickness trouble in the United States. This stimulates the need to inject nutritional fluids that contain glutamine, phospholipids, glucose, and amino acids for better overall health of human body, which thus, is expected to help the market development around these regions. With the provision of medications in home settings, patients recover quicker, are more conformable, and home infusion therapy is rather a pocket friendly option.
The key factors driving the market incorporate the expanding geriatric population with diminished opportunity to maintain healthy lifestyle choices, rising inclination for home treatment consideration during less serious illnesses, and quick innovative progressions taking place in medical infusion equipment.
Global Home Infusion Therapy Market Value Share Analysis, by Geography (2022)
The report titled “Global Home Infusion Therapy Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global home infusion therapy market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global home infusion therapy market is segmented based on product type, application type, and region. Based on product type, the market is classified into Infusion Pumps (Elastomeric, Electromechanical, Gravity, Others.), Intravenous Sets, IV Cannulas, Needleless Connectors, and others. Based on application type, global home infusion therapy market is segmented into Anti-infective, Endocrinology (Diabetes, Others.), Hydration Therapy (Athletes, Others.), Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, Others. Based on geography, the global home infusion therapy market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada, and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Italy, France, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on global home infusion therapy market. Further, market share of prominent companies in the global home infusion therapy market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Home Infusion Therapy companies. The global home infusion therapy market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.
Product portfolio would focus on all the products under the Home Infusion Therapy business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global home infusion therapy market.
The key players of the global home infusion therapy market are CVS/Coram, Option Care Health, BriovaRx/Diplomat (United Health Optum), PharMerica, Fresenius Kabi, ICU Medical, Inc., B. Braun Melsungen AG, Baxter, BD, Caesarea Medical Electronics, Smiths Medical, Terumo Corporation, JMS Co. Ltd.
Global Home Infusion Therapy Market Key Segments:
By Product Type
By Application Type
By Region
The home infusion therapy analysis market has been assessed for the years 2019 to 2032.
The key factors driving the market incorporate the expanding geriatric population with diminished opportunity to maintain healthy lifestyle choices, rising inclination for home treatment consideration during less serious illnesses, and quick innovative progressions taking place in medical infusion equipment.
Home infusion therapy are largely used in the Anti-infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals and Others.
Major players operating in the global home infusion therapy market include CVS/Coram, Option Care Health, BriovaRx/Diplomat (United Health Optum), PharMerica, Fresenius Kabi, ICU Medical, Inc., B. Braun Melsungen AG, Baxter, BD, Caesarea Medical Electronics, Smiths Medical, Terumo Corporation, JMS Co. Ltd.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved